MAISON BLANCHE, LLC – Trademark Portfolio
Entity Type: 16
MAISON BLANCHE, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include NO 93 and MAISON BLANCHE. The owner is based in Houston, TX.
5773 Woodway Drive, No. 80
Houston, TX 77057
Showing of trademarks Trademarks
Trademark Classifications
MAISON BLANCHE, LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does MAISON BLANCHE, LLC have?
MAISON BLANCHE, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.
What trademark classes does MAISON BLANCHE, LLC file in?
MAISON BLANCHE, LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning), Class 20 (Furniture), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MAISON BLANCHE, LLC's most well-known trademarks?
MAISON BLANCHE, LLC's registered trademark portfolio includes well-known marks such as NO 93 and MAISON BLANCHE. These are among 2 currently registered trademarks in the portfolio.
What is MAISON BLANCHE, LLC's trademark registration success rate?
MAISON BLANCHE, LLC has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.